期刊文献+

探讨普罗帕酮联合美托洛尔对小儿心律失常的临床疗效 被引量:6

下载PDF
导出
摘要 目的:对普罗帕酮联合美托洛尔治疗小儿心律失常的临床效果进行分析和探讨。方法选取2012年11月~2013年11月期间在我院住院治疗的心律失常患儿52例,随机分为治疗组26例与对照组26例。对照组患儿使用普罗帕酮进行治疗,治疗组患儿使用普罗帕酮联合美托洛尔进行治疗,对两组患儿的治疗效果和不良反应进行对比分析。结果治疗组患儿的总有效率为92.31%,对照组患儿的总有效率为73.08%,两组患儿的临床疗效具有显著性差异,P<0.05。不良反应之间没有显著性差异, P>0.05。治疗组患儿在治疗后的房性早搏、室性早搏、短阵房速、短阵室速发作次数少于对照组,两组之间具有显著性差异, P<0.05。结论普罗帕酮联合美托洛尔治疗小儿心律失常的临床效果较为理想。
作者 尹吕清
机构地区 嘉鱼妇幼保健院
出处 《航空航天医学杂志》 2014年第4期520-521,共2页 Journal of Aerospace medicine
  • 相关文献

参考文献5

二级参考文献17

  • 1陈张虎,王晓明.胺碘酮治疗充血性心力衰竭合并室性心律失常96例[J].第四军医大学学报,2006,27(2). 被引量:25
  • 2李学斌.阵发性室上性心动过速的药物治疗[J].实用心脑肺血管病杂志,2006,14(2):87-88. 被引量:4
  • 3高鑫,朱俊,杨艳敏,李建东,杨志敏,刘静涵,无.盐酸关附甲素与普罗帕酮对比终止阵发性室上性心动过速的随机双盲多中心试验[J].中华心血管病杂志,2007,35(2):151-154. 被引量:20
  • 4[1]Kenneth A, Pramod K, James R, et al. Atrial Natriuretic factor release is enhanced by incremental atrial pacing [J]. Am Heart J, 1998,116:489.
  • 5[2]Bates ER, Roger J, Grekin P, et al. The relationship between plasma ANP and hemodynamic Function in man [J].Circulation, 1986,73:1155.
  • 6[3]Guccione P, Drago F, Donato R, et al. Oral Propafenone therapy for children with arrhythmias: efficacy and adverse effects in midterm follow-up[J].Am Heart J, 1999,122(4):1022.
  • 7陈维洲.抗心律失常药.心血管药理学.科学出版社,2001:256-261.
  • 8Moore R, Gordon Hickey S, Jones A et al. Most comfortable listening levels, background noise levels, and acceptable noise levels for children and adults with normal hearing [J] . Journal of the American Academy of Audiology, 2011, 22 (5) : 286.
  • 9Carobbi CFM, Simone Lazzerini, Millanta LM et al. High - frequency operation of the coils for standard magnetic - field generation using the bulk - current technique[J] . IEEE Transactions on Instrumentation and Measurement, 2005, 54 (4): 1427.
  • 10Palardy M, Ducharme A, Nattel Set al. Absence of protecti, e effect of renin- angiotensin system inhibitors on atnat iibrttia- tion development : insights from the Canadian Trial of Atrial Fi- brillation (CTAF) [J]. The Canadian Journal of Cardiology, 2008, 24 (9): 709.

共引文献26

同被引文献29

  • 1段彩玉.稳心颗粒联合美托洛尔治疗冠心病室性心律失常的疗效及不良反应[J].中外医疗,2012,31(28):110-111. 被引量:16
  • 2林元涛,徐艳.普罗帕酮与美托洛尔联用治疗小儿心律失常的临床疗效分析[J].医药前沿,2012,02(14):101-102.
  • 3Rodo X, Curcoll R, Robinson M, et al. Tropospheric winds from northeastern China carry the etiologic agent of Kawasaki disease from its source to Japan[J]. Proc Natl Acad Sci U S A,2014,111 (22) : 7952-7957.
  • 4KassamaliR H, Kim D H, Patel H, et al. Safety of an i.v. β- adrenergic blockade protocol for heart rate optimization before coronary CT angiography [J]. A JR Am J Roentgenol, 2014,203 ( 4 ) : 759-762.
  • 5Kim J W, Goo H W. Coronary artery abnormalities in Kawasaki disease: comparison between CT and MR coronary angiography[J]. Acta Radiologica, 2013, 54(2):156-163.
  • 6Song Y H. A Memory Molecule, Ca (2 + )/Calmodulin-Dependent Protein Kinase II and Redox Stress; Key Factors for Arrhythmias in a Diseased Heart [J]. Korean Circ J,2013,43 ( 3 ) : 145-151.
  • 7Giannouli G, Tzoumaka-Bakoula C, Kopsidas I, et al. Epidemiology and risk factors for coronary artery abnormalities in children with complete and incomplete Kawasaki disease during a 10- year period[J]. Pediatric cardiology ,2013,34(6 ) : 1476-1481.
  • 8Sohinki D, Obel O A. Current trends in supraventricular tachycardia management[J]. Ochsner Journal, 2014, 14 (4) : 586- 595.
  • 9Rostock T, Salukhe T V, Hoffmann B A, et al. Prognostic role of subsequent atrial tachycardias occurring during ablation of persistent atrial fibrillation : a prospective randomized trial [J]. Circ Arrhythm Electrophysiol,2013,6 (6) : 1059 - 1065.
  • 10Giannouli G, Tzoumaka-Bakoula C, Kopsidas I, et aL Epidemiology and risk factors for coronary artery abnormalities in children with complete and incomplete Kawasaki disease during a 10- year period[J]. Pediatric cardiology ,2013,34(6 ) : 1476-1481.

二级引证文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部